Centrum Medyczne ENEL-MED S.A.

WSE:ENE Stock Report

Market Cap: zł551.5m

Centrum Medyczne ENEL-MED Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Centrum Medyczne ENEL-MED.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth20.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

May 30
Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)

Apr 21
Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)

Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business

May 12
Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business

Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?

Jun 09
Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?

Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?

Feb 22
Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?

We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt

Feb 01
We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt

We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential

Jan 11
We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential

Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?

Dec 21
Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?

Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?

Nov 30
Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Centrum Medyczne ENEL-MED has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

WSE:ENE - Analysts future estimates and past financials data (PLN Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2024654165095N/A
12/31/202361984881N/A
9/30/202358972766N/A
6/30/202355702064N/A
3/31/2023522-23353N/A
12/31/2022495-24-640N/A
9/30/2022476-30-445N/A
6/30/2022476-27-346N/A
3/31/2022450-71759N/A
12/31/2021441-12967N/A
9/30/2021427-33056N/A
6/30/2021419-14158N/A
3/31/202139846577N/A
12/31/2020400-36374N/A
9/30/202040747688N/A
6/30/2020410-17790N/A
3/31/2020424-84367N/A
12/31/2019418-24575N/A
9/30/2019406-73061N/A
6/30/2019393-1740N/A
3/31/2019382-3630N/A
12/31/2018372-1-515N/A
9/30/2018360-7-711N/A
6/30/2018350-9-220N/A
3/31/2018338-5-227N/A
12/31/2017324-3N/A24N/A
9/30/20173092N/A30N/A
6/30/20172964N/A26N/A
3/31/20172853N/A20N/A
12/31/20162742N/A17N/A
9/30/20162651N/A18N/A
6/30/2016254-1N/A12N/A
3/31/2016244-2N/A11N/A
12/31/20152351N/A16N/A
9/30/20152262N/A8N/A
6/30/20152194N/A11N/A
3/31/201521642N/A13N/A
12/31/201421442N/A12N/A
9/30/201421643N/A16N/A
6/30/201421842N/A21N/A
3/31/20142124N/A18N/A
12/31/20132072N/A18N/A
9/30/2013197-2N/A17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ENE's forecast earnings growth is above the savings rate (3.9%).

Earnings vs Market: Insufficient data to determine if ENE's earnings are forecast to grow faster than the Polish market

High Growth Earnings: Insufficient data to determine if ENE's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ENE's revenue is forecast to grow faster than the Polish market.

High Growth Revenue: Insufficient data to determine if ENE's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ENE's Return on Equity is forecast to be high in 3 years time


Discover growth companies